Pfizer unveils last phase of Adelaide hub

Pfizer has unveiled the final phase of its $21 million investment which it says will establish Adelaide as a global manufacturing hub for a medicine commonly used to treat complications in people with cancer. The multi-million dollar upgrade to the Adelaide manufacturing facility is set to be completed in mid-2016, allowing for the production and